Project description
Proteolysis-targeting chimeric technology in the development of anticancer drugs
Fields of science
- medical and health sciencesbasic medicinemedicinal chemistry
- natural sciencesbiological sciencesbiochemistrybiomoleculesproteins
- medical and health sciencesclinical medicineoncology
- medical and health sciencesbasic medicinepharmacology and pharmacydrug resistance
- medical and health scienceshealth sciences
Programme(s)
Funding Scheme
MSCA-IF-EF-ST - Standard EFCoordinator
FUNDACION UNIVERSITARIA SAN PABLO-CEU
Net EU contribution
€ 172 932,48
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 0,00
Region
Madrid Comunidad de Madrid